CLINICAL ROLE -
FDA Approves New Herpes Zoster Vaccine
Singrix is a recombinant vaccine indicated for the prevention of herpes zoster in older adults.
Read More
Benefits of Value-Based Healthcare Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
FDA Approves Herpes Zoster Vaccine
By preventing shingles, Shingrix also reduced the overall incidence of postherpetic neuralgia (PHN).
Vitamin D Deficiency During Pregnancy Impacts Childhood Development
Inadequate vitamin D during pregnancy may lead to children having stunted social and motor skills.
HIV-Positive Children Over Diagnosed with Asthma
Many children with HIV who are diagnosed with asthma may actually have chronic obstructive lung disease.
Gaps in Primary Care Exist After Emergency Department Visits
Medicaid-insured beneficiaries less likely to receive prompt primary care following an emergency department visit.
Chinese Manufacturers Indicted Over Fentanyl, Opioid Distribution
Government investigation reveals a flood of opioids being sent from China.
Pharmacy Week in Review: October 20, 2017
A look at last week's top stories in the world of pharmacy.
Watch
A look at last week's top stories in the world of pharmacy.
Trending News Today: Bipartisan Healthcare Stabilization Bill Gains Momentum
Top news of the day from across the healthcare landscape.
Trending News Today: Cancer Drug Costs Increase Above Inflation Rate
Importance of Mammography Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
National Mammography Day Encourages Breast Cancer Screening
Mammography plays an important role in breast cancer detection.
FDA Halts Crohn's Disease Trial
The FDA a stop to Celgene’s REVOLVE trial and extension trial for GED-0301 (mongersen), an oral compound currently not approved for any uses.
Importance of Breast Cancer Screening Highlighted on National Mammography Day
Early detection is crucial for breast cancer survival.
How to Improve Outcomes for Asthma Patients
Pharmacists are in a prime position to offer guidance to those who have this often under-treated chronic disease.
Breaking Through Breakthrough Cancer Pain
Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled
Evolving Your Pharmacy Practice in an Era of Great Change
Pharmacists can finally move ‘beyond the script’ and get paid for more than dispensing medications through opportunities to get paid for providing total care and support for the patient.
NIH Partnership Seeks to Advance Cancer Immunotherapy Research
The Partnership for Accelerating Cancer Therapies seeks to standardize biomarkers for cancer immunotherapy drugs.
FDA Approves Non-Hodgkin Lymphoma Gene Therapy
This is the first gene therapy to be approved for non-Hodgkin lymphoma (NHL), according to the FDA.
End to HIV/AIDS Pandemic Contingent on Vaccine Development
Moderately effective vaccine could boost efforts to cure HIV.
What Is Your Pharmaceutical Footprint?
For much of my career, we discarded, flushed, or poured down the drain those medications that were past the labeled expiration date but still probably 95% active.
Top 5 Low-Value Services Driving Healthcare Spending
Unnecessary healthcare services cost the United States billions each year.
OTC Allergy Drug May Restore Nerve Cell Signaling in Multiple Sclerosis Patients
Allergy medication may cause remyelination in humans with multiple sclerosis.
Ketogenic Diet Suppresses Brain Inflammation
A ketogenic state may provide benefits for patients with diabetes.
Double Dosing: Helping Patients Understand the Risks During Cold Season
It’s a good time to talk to patients about the potential risks of taking over-the- counter (OTC) cold and flu medication and other OTC or prescription analgesics and antipyretics concomitantly.
Trending News Today: Fate of Healthcare Stabilization Uncertain
Top news from across the healthcare landscape.
Trending News Today: More Than Half of States Still Expanding Medicaid Benefits
FDA Approves Second Gene Therapy for Cancer
Axicabtagene ciloleucel (Yescarta) indicated for the treatment of adults with diffuse large B-cell lymphoma.
FDA Approves Lymphoma Gene Therapy
FDA says ‘yes’ to axicabtagene ciloleucel (Yescarta), a gene therapy for lymphoma.